241 related articles for article (PubMed ID: 26365437)
1. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
[TBL] [Abstract][Full Text] [Related]
2. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
3. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
4. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
5. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
6. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
[TBL] [Abstract][Full Text] [Related]
7. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
[TBL] [Abstract][Full Text] [Related]
8. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z
Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337
[TBL] [Abstract][Full Text] [Related]
9. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
[TBL] [Abstract][Full Text] [Related]
10. MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.
Tian T; Wang M; Zhu W; Dai ZM; Lin S; Yang PT; Liu XH; Liu K; Zhu YY; Zheng Y; Liu M; Dai ZJ
Aging (Albany NY); 2017 Jan; 9(2):381-392. PubMed ID: 28148887
[TBL] [Abstract][Full Text] [Related]
11. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
12. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
13. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.
Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S
J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726
[TBL] [Abstract][Full Text] [Related]
14. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
15. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
[TBL] [Abstract][Full Text] [Related]
16. Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.
Zhang T; Liu Y; Peng X; Fan J; Peng Z
Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948
[TBL] [Abstract][Full Text] [Related]
17. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.
Li XD; Li ZG; Song XX; Liu CF
Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878
[TBL] [Abstract][Full Text] [Related]
18. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
